Table 1.
Case 1 |
Case 2 |
Case 3 |
Case 4 |
||||||
---|---|---|---|---|---|---|---|---|---|
39 WG | 2 months PP | 20 WG | 2 months PP | 16 WG | 3 months PP | 4 days PP | 10 months PP | ||
TSH (mU/L) | 1.64 | 0.56 | 0.22 | 3.69 | 0.75 | 0.47 | 1.42 | 2.42 | |
FT4 (pmol/L) | 12.3 | 14.2 | 14.7 | 13.5 | 15.2 | 11.3 | – | 13.3 | |
Prolactin (μg/L) | 391 | 13.5 | 7.2 | 145.8 | 12.1 | 18.3 | 20.2 | 5.2 | |
Cortisol (nmol/L) | 475 | 310 | 756 | 281 | 347 | 170 | 64 | 485 | |
ACTH (pmol/L) | 12.5 | – | – | – | – | – | – | – | |
IGF-1 (μg/L) | 253 | – | – | 190 | 110 | 158 | – | 51 | |
Urinary free cortisol (nmol/24 h) | – | – | 459 | - | 445 | – | – | 343 (on treatment) |
Reference range in general population: TSH: thyroid stimulating hormone, 0.35–5.50 mU/L; FT4: free thyroxine, 10.0–23.0 pmol/L; Prolactin, 3.0–29.0 μg/L; Cortisol, 119.0–618.0 nmol/L; ACTH: adrenocorticotropic hormone, 2.0–11.0 pmol/L; IGF-1: insulin growth factor, 95.0–320.0 μg/L; Urinary free cortisol, < 220 nmol/24 h; PP: post-partum; WG: week of gestation; CHUM: Centre hospitalier de l'Université de Montréal.